top of page
Advocating, Accelerating, and Amplifying Lung Cancer Discovery
Advocating, Accelerating, and Amplifying Lung Cancer Discovery

Thu, Aug 03



Advocating, Accelerating, and Amplifying Lung Cancer Discovery

Registration is closed
See other events

Time & Location

Aug 03, 2023, 3:00 PM – 4:00 PM


About the Event

  1. Video replay lWatch

The Lung-MAP Accrual Enhancement Committee (AEC) is pleased to host an upcoming public webinar titled, 

Advocating, Accelerating, and Amplifying Lung Cancer Discovery. 

The webinar will feature experts from the current Lung-MAP clinical trial to discuss recent trial updates, challenges to the traditional clinical trial landscape that Lung-MAP is working to overcome, and opportunities for patient engagement in the process. Importantly, the webinar will feature a panel discussion among lung cancer advocates with their perspectives on these topics.

Lung-MAP is a cancer clinical trial designed to quickly and efficiently test new treatments for advanced non-small cell lung cancers – which make up about 85 percent of all lung cancer diagnoses in the United States. Lung-MAP is offered at hospitals and clinics all over the country, making it easier for lung cancer patients to participate and get access to investigational treatments to fight their cancer.   We will include time for attendee Q&A during the webinar.


3:00PM – Welcome Remarks

  • Ryan Hohman, Vice President – Public Affairs, Friends of Cancer Research

Welcome and Lung-MAP Overview

  • Dr. Karen Reckamp, Director, Division of Medical Oncology, Cedars-Sinai Medical Center, Lung-MAP Vice Chair – S2302 Pragmatica-Lung

3:05PM – Lung-MAP Today: Accelerating Lung Cancer Discovery

  • Moderator: Judy Johnson, MBA, SWOG Lung Committee Patient Advocate, Member of AEC

Updates on Current Studies: S1900E & S2302 Pragmatica-Lung

  • Dr. Sukhmani Padda, Director, Thoracic Medical Oncology, Cedars-Sinai Cancer Center – S1900E
  • Dr. Karen Reckamp, Lung-MAP Vice Chair

Updates on New Studies: S1900G

  • Dr. Karen Reckamp, Lung-MAP Vice Chair

Lung-MAP Opportunities and Challenges of Enrollment from a Clinician’s Perspective

  • Dr. Jay Nayak, AnMed Health Cancer Center

3:30 PM – Panel: Amplifying Patient Voices

  • Moderator: Ryan Hohman, Friends of Cancer Research
  • Terri Conneran, KRAS Kickers
  • Ivy Elkins, EGFR Resisters
  • Dr. Upal Basu Roy, LUNGevity

3:58PM – Closing remarks

  • Frank DeSanto, Communications and Public Relations Manager, SWOG Cancer Research Network

Lung-MAP is a groundbreaking public-private partnership that includes the NCI and its National Clinical Trials Network (NCTN) including SWOG Cancer Research Network, Friends of Cancer Research, the Foundation for the National Institutes of Health (FNIH), Foundation Medicine, pharmaceutical companies which provided their drugs for the study, and several lung cancer advocacy organizations.

Share This Event

bottom of page